Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02688140
Title Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia (TUD-APOLLO-064)
Acronym TUD-APOLLO-064
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Technische Universität Dresden
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ITA | FRA | ESP | DEU

Facility Status City State Zip Country Details
French-Belgian-Swiss APL study group Multiple Locations France Details
AML-CG study group Multiple Locations Germany Details
AML-SG study group Multiple Locations Germany Details
OSHO study group Multiple Locations Germany Details
SAL study group Multiple Locations Germany Details
GIMEMA study group Multiple Locations Italy Details
HOVON study group Multiple Locations Netherlands Details
PETHEMA study group Multiple Locations Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field